Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
Noosa News12 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General9 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News11 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News10 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor